project id: TCGA-SKCM; case submitter id: TCGA-D3-A3C8; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.3; rna integrity number: 7.3; age at index: 58; days to birth: -21281; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1951; age at diagnosis: 21281; ajcc pathologic m: M0; ajcc pathologic n: N3; ajcc pathologic stage: Stage IIIC; ajcc pathologic t: TX; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1409.0; icd 10 code: C49.0; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Connective, subcutaneous and other soft tissues of head, face, and neck; synchronous malignancy: Not Reported; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 736; days to sample procurement: 0; initial weight: 70.0; portion submitter id: TCGA-D3-A3C8-06A-12; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 5.0; percent necrosis: 2.0; percent neutrophil infiltration: 0.0; percent normal cells: 5.0; percent stromal cells: 3.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0;